Australia: Clarification on quality standards, use of synthetics, and labelling and packaging requirements for medicinal cannabis products April 29, 2022 By Helen Macpherson, Alanna Rennie and Anita Juric 1 Min Read Share Share on Facebook Share on Twitter Email Baker McKenzie’s Global Compliance News Blog published “Australia: Clarification on quality standards, use of synthetics, and labelling and packaging requirements for medicinal cannabis products,” which can be viewed here. 0 Author Helen Macpherson Author Alanna Rennie Author Anita Juric Related Posts Update to UKCA marking transition August 2, 2022 EU: European Court of Justice clarifies concept of related persons for customs purposes July 1, 2022 Turkey: Amendments to the Customs Regulation in Turkey June 27, 2022
